[go: up one dir, main page]

DK1093813T3 - Fremgangsmåde til at fremstille polymer-overtrukket tablet, der omfatter amoxycillin og clavunalat, belagt med et vandigt polymerfilmovertræk - Google Patents

Fremgangsmåde til at fremstille polymer-overtrukket tablet, der omfatter amoxycillin og clavunalat, belagt med et vandigt polymerfilmovertræk

Info

Publication number
DK1093813T3
DK1093813T3 DK00204182T DK00204182T DK1093813T3 DK 1093813 T3 DK1093813 T3 DK 1093813T3 DK 00204182 T DK00204182 T DK 00204182T DK 00204182 T DK00204182 T DK 00204182T DK 1093813 T3 DK1093813 T3 DK 1093813T3
Authority
DK
Denmark
Prior art keywords
coated
clavunalate
amoxycillin
film coating
polymeric film
Prior art date
Application number
DK00204182T
Other languages
Danish (da)
English (en)
Inventor
Creighton Pierce Conley
Nigel Philip Mccreath Davidson
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10754044&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1093813(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Application granted granted Critical
Publication of DK1093813T3 publication Critical patent/DK1093813T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42Oxazoles
    • A61K31/424Oxazoles condensed with heterocyclic ring systems, e.g. clavulanic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • A61K31/429Thiazoles condensed with heterocyclic ring systems
    • A61K31/43Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/28Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806Coating materials
    • A61K9/2833Organic macromolecular compounds
    • A61K9/2853Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers, poly(lactide-co-glycolide)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/28Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806Coating materials
    • A61K9/2833Organic macromolecular compounds
    • A61K9/286Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/28Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2893Tablet coating processes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
DK00204182T 1994-04-23 1995-04-19 Fremgangsmåde til at fremstille polymer-overtrukket tablet, der omfatter amoxycillin og clavunalat, belagt med et vandigt polymerfilmovertræk DK1093813T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB9408117A GB9408117D0 (en) 1994-04-23 1994-04-23 Pharmaceutical formulations

Publications (1)

Publication Number Publication Date
DK1093813T3 true DK1093813T3 (da) 2003-02-17

Family

ID=10754044

Family Applications (4)

Application Number Title Priority Date Filing Date
DK00204182T DK1093813T3 (da) 1994-04-23 1995-04-19 Fremgangsmåde til at fremstille polymer-overtrukket tablet, der omfatter amoxycillin og clavunalat, belagt med et vandigt polymerfilmovertræk
DK95917937T DK0758235T3 (da) 1994-04-23 1995-04-19 Polymercoatet tablet omfattende amoxycillin og clavulanat
DK96202848T DK0761218T3 (da) 1994-04-23 1995-04-19 Fremgangsmåde til fremstilling af polymerovertrukne tabletter omfattende amoxycillin og clavulanat
DK99200891T DK0978276T3 (da) 1994-04-23 1995-04-19 Polymerovertrukken tablet omfattende amoxycillin og clavulanat

Family Applications After (3)

Application Number Title Priority Date Filing Date
DK95917937T DK0758235T3 (da) 1994-04-23 1995-04-19 Polymercoatet tablet omfattende amoxycillin og clavulanat
DK96202848T DK0761218T3 (da) 1994-04-23 1995-04-19 Fremgangsmåde til fremstilling af polymerovertrukne tabletter omfattende amoxycillin og clavulanat
DK99200891T DK0978276T3 (da) 1994-04-23 1995-04-19 Polymerovertrukken tablet omfattende amoxycillin og clavulanat

Country Status (35)

Country Link
US (1) US6051255A (el)
EP (5) EP1243267A3 (el)
JP (1) JP3622975B2 (el)
CN (1) CN1134258C (el)
AP (2) AP564A (el)
AT (6) ATE203161T1 (el)
AU (1) AU684949B2 (el)
BG (1) BG62842B1 (el)
BR (1) BR9507502A (el)
CA (1) CA2188496A1 (el)
CZ (2) CZ11376U1 (el)
DE (5) DE69519093T2 (el)
DK (4) DK1093813T3 (el)
DZ (1) DZ1876A1 (el)
ES (4) ES2182754T3 (el)
FI (1) FI964249A7 (el)
GB (1) GB9408117D0 (el)
GR (2) GR3035031T3 (el)
HK (1) HK1050992A1 (el)
HU (1) HU228399B1 (el)
IL (1) IL113433A (el)
MA (1) MA23528A1 (el)
MY (1) MY115351A (el)
NO (1) NO310703B1 (el)
NZ (1) NZ285080A (el)
OA (1) OA10377A (el)
PL (1) PL316966A1 (el)
PT (4) PT761218E (el)
RO (1) RO116997B1 (el)
RU (1) RU2152213C1 (el)
SA (1) SA95160343B1 (el)
SI (1) SI0758235T1 (el)
SK (1) SK282594B6 (el)
WO (1) WO1995028927A1 (el)
ZA (1) ZA953236B (el)

Families Citing this family (70)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9407386D0 (en) 1994-04-14 1994-06-08 Smithkline Beecham Plc Pharmaceutical formulation
GB9408117D0 (en) * 1994-04-23 1994-06-15 Smithkline Beecham Corp Pharmaceutical formulations
DZ2028A1 (fr) * 1995-05-03 2002-10-23 Smithkline Beecham Plc Médicaments destinés au traitement d'infections bactériennes en pédiatrie.
US20030109503A1 (en) * 1995-06-06 2003-06-12 Smithkline Beecham P.L.C. Pharmaceutical formulations comprising clavulanic acid alone or in combination with other beta-lactam antibiotics
WO1997009042A1 (en) 1995-09-07 1997-03-13 Smithkline Beecham Corporation Pharmaceutical formulation
AT403375B (de) * 1995-11-15 1998-01-26 Biochemie Gmbh Verfahren zur fällung von alkalisalzen der clavulansäure
TWI225402B (en) * 1996-03-13 2004-12-21 Biochemie Gmbh Auxiliary-free agglomerates
AT407701B (de) * 1996-08-12 2001-05-25 Biochemie Gmbh Zur direkttablettierung geeignete mischung, die als wesentliche komponenten amoxicillin-trihydrat und das kaliumsalz der clavulansäure enthält und verfahren zur herstellung dieser mischung
GB9613470D0 (en) 1996-06-27 1996-08-28 Ciba Geigy Ag Small solid oral dosage form
GB9616536D0 (en) 1996-08-06 1996-09-25 Quadrant Holdings Cambridge Co-amoxiclav dosage form
GB9617780D0 (en) * 1996-08-24 1996-10-02 Smithkline Beecham Plc Method of treatment
AU6496498A (en) * 1997-02-07 1998-08-26 Gist-Brocades B.V. Homogeneous granulated formulations for dose sipping technology
CN1194687C (zh) * 1997-02-14 2005-03-30 史密斯克莱恩比彻姆药物实验室 含有阿莫西林和克拉维酸盐的药物制剂
US20030124187A1 (en) * 1997-02-14 2003-07-03 Smithkline Beecham Laboratoires Pharmaceutiques, Pharmaceutical formulations comprising amoxycillin and clavulanate
TR200000529T2 (tr) * 1997-08-29 2000-08-21 Dsm N.V. İçinde eksipiyan olmayan granüller
WO1999022769A1 (en) 1997-10-31 1999-05-14 Monsanto Company Gellan gum tablet coating
EP1165049B2 (en) 1999-04-01 2011-07-06 DSM IP Assets B.V. Agglomerates by crystallisation
AU767177B2 (en) * 1999-04-13 2003-11-06 Beecham Pharmaceuticals (Pte) Limited Novel method of treatment
US6294199B1 (en) * 1999-04-13 2001-09-25 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection comprising administering amoxycillin
US7250176B1 (en) * 1999-04-13 2007-07-31 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection
US6878386B1 (en) 1999-04-13 2005-04-12 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection comprising amoxycillin and potassium clavulanate
US20040038948A1 (en) 1999-12-07 2004-02-26 Uhrich Kathryn E. Therapeutic compositions and methods
GB9930578D0 (en) * 1999-12-23 2000-02-16 Smithkline Beecham Plc Pharmaceutical formulations
US6544555B2 (en) 2000-02-24 2003-04-08 Advancis Pharmaceutical Corp. Antibiotic product, use and formulation thereof
US6565882B2 (en) * 2000-02-24 2003-05-20 Advancis Pharmaceutical Corp Antibiotic composition with inhibitor
WO2002002081A1 (en) * 2000-07-05 2002-01-10 Capricorn Pharma, Inc. Rapid-melt semi-solid compositions, methods of making same and methods of using same
US6375982B1 (en) * 2000-07-05 2002-04-23 Capricorn Pharma, Inc. Rapid-melt semi-solid compositions, methods of making same and method of using same
US6756057B2 (en) * 2000-10-12 2004-06-29 Beecham Pharmaceuticals (Pte) Limited Amoxicillin and potassium clavulanate dosage form
WO2002030392A2 (en) * 2000-10-12 2002-04-18 Beecham Pharmaceuticals (Pte) Limited Formulation containing amoxicillin
US6541014B2 (en) * 2000-10-13 2003-04-01 Advancis Pharmaceutical Corp. Antiviral product, use and formulation thereof
US20020068078A1 (en) * 2000-10-13 2002-06-06 Rudnic Edward M. Antifungal product, use and formulation thereof
US20020197314A1 (en) * 2001-02-23 2002-12-26 Rudnic Edward M. Anti-fungal composition
US20040156900A1 (en) * 2001-04-10 2004-08-12 Shanghvi Dilip Shantilal Time pulsed release composition
US20030070584A1 (en) * 2001-05-15 2003-04-17 Cynthia Gulian Dip coating compositions containing cellulose ethers
AU4061702A (en) * 2001-05-15 2003-04-03 Mcneil-Ppc, Inc. Dip coating compositions containing starch or dextrin
US8309118B2 (en) * 2001-09-28 2012-11-13 Mcneil-Ppc, Inc. Film forming compositions containing sucralose
AU2003210925A1 (en) * 2002-02-07 2003-09-02 Rutgers, The State University Antibiotic polymers
DE60306120T2 (de) * 2002-02-14 2006-11-09 Glaxo Group Ltd., Greenford Pharmazeutische formulierung, die n-((1-n-butyl-4-piperidinyl)menthyl)-3,4-dihydro-2h-(1,3)oxazino(3,2-a)indol-10-carboxamid oder ein entsprechendes salz hiervon enthält, sowie deren herstellungsprozess, welcher trockengranulierung beinhaltet
GB0203528D0 (en) * 2002-02-14 2002-04-03 Glaxo Group Ltd Process and composition
US20060083759A1 (en) * 2002-07-17 2006-04-20 Aleksander Resman Stabilization of the profile of release of active substances from a formulation
US8637512B2 (en) 2002-07-29 2014-01-28 Glaxo Group Limited Formulations and method of treatment
KR100456833B1 (ko) * 2002-08-01 2004-11-10 주식회사 대웅 아목시실린 및 클라불라네이트를 함유하는 유핵정
US7429619B2 (en) * 2002-08-02 2008-09-30 Mcneil Consumer Healthcare Polyacrylic film forming compositions
CA2406592C (en) * 2002-10-04 2003-09-30 Duchesnay Inc. Method of preparing pharmaceutical dosage forms containing multiple active ingredients
US7405210B2 (en) 2003-05-21 2008-07-29 Osi Pharmaceuticals, Inc. Pyrrolopyridine-2-carboxylic acid amide inhibitors of glycogen phosphorylase
US8425936B2 (en) * 2003-07-21 2013-04-23 Shionogi Inc. Antibiotic product, use and formulation thereof
CA2533292C (en) 2003-07-21 2013-12-31 Advancis Pharmaceutical Corporation Antibiotic product, use and formulation thereof
US8313776B2 (en) * 2003-07-21 2012-11-20 Shionogi Inc. Antibiotic product, use and formulation thereof
JP2007502296A (ja) * 2003-08-11 2007-02-08 アドバンシス ファーマスーティカル コーポレイション ロバストペレット
EP1653924A4 (en) 2003-08-12 2009-09-09 Middlebrook Pharmaceuticals In ANTIBIOTICS, USE AND FORMULATION ASSOCIATED
JP5686494B2 (ja) * 2003-08-29 2015-03-18 シオノギ インコーポレイテッド 抗生物質製剤、その使用法及び作成方法
DE10341264A1 (de) * 2003-09-04 2005-03-24 Grünenthal GmbH Schmelzformulierte, multipartikuläre orale Darreichungsform
EP1663169A4 (en) * 2003-09-15 2010-11-24 Middlebrook Pharmaceuticals In ANTIBIOTICS, ITS USE AND FORMULATION
EP1701705A4 (en) * 2003-12-24 2007-08-08 Advancis Pharmaceutical Corp IMPROVED ABSORPTION OF DOSAGE FORMS WITH MODIFIED RELEASE
JP2007527904A (ja) 2004-03-08 2007-10-04 プロシディオン・リミテッド グリコーゲンホスホリラーゼ阻害剤としてのピロロピリジン−2−カルボン酸ヒドラジド化合物
CA2572292A1 (en) * 2004-07-02 2006-02-09 Advancis Pharmaceutical Corporation Tablet for pulsed delivery
KR100638315B1 (ko) * 2004-07-23 2006-10-25 주식회사 대웅제약 다중 필름 코팅된 코어층을 갖는 클라불라네이트 및아목시실린-함유 유핵정
CN101171006B (zh) 2005-05-20 2010-12-01 第一三共株式会社 薄膜包衣制剂
KR100780553B1 (ko) * 2005-08-18 2007-11-29 한올제약주식회사 메트포르민 서방정 및 그의 제조방법
US8357394B2 (en) 2005-12-08 2013-01-22 Shionogi Inc. Compositions and methods for improved efficacy of penicillin-type antibiotics
US8778924B2 (en) * 2006-12-04 2014-07-15 Shionogi Inc. Modified release amoxicillin products
US8299052B2 (en) 2006-05-05 2012-10-30 Shionogi Inc. Pharmaceutical compositions and methods for improved bacterial eradication
CL2008003230A1 (es) * 2007-11-01 2009-11-27 Sanofi Aventis Healthcare Pty Ltd Composicion de recubrimiento de tableta que comprende polimero celulosico, plastificante, edulcorante y composicion de sabor en polvo la que comprende saborizante asociado con portador solido; fluido de recubrimiento de tableta que comprende dicha composicion; tableta farmaceutica; proceso de preparacion de dicha tableta.
RU2012115459A (ru) * 2009-09-18 2013-10-27 Санофи Таблетируюмый препарат (4'-трифторметилфенил)амида (z)-2-циано-3-гидрокси-бут-2-еноевой кислоты с улучшенной устойчивостью
TR200909787A2 (tr) 2009-12-25 2011-07-21 Bi̇lgi̇ç Mahmut Üçüncü kuşak bir sefalosporin ve klavulanik asit içeren farmasötik formülasyonlar.
TR201000687A1 (tr) 2010-01-29 2011-08-22 Bi̇lgi̇ç Mahmut Aktif madde olarak sefiksim ve klavulanik asit içeren efervesan formülasyonlar
TR201000686A1 (tr) 2010-01-29 2011-08-22 B�Lg�� Mahmut Bakteriyel enfeksiyonların tedavisinde suda çözünebilir sefdinir ve klavulanik asit formülasyonları.@
TR201000688A2 (tr) 2010-01-29 2011-08-22 B�Lg�� Mahmut Aktif madde olarak sefaklor ve klavulanik asit içeren efervesan formülasyonlar.
JP6041591B2 (ja) * 2011-09-13 2016-12-14 大日本住友製薬株式会社 イルベサルタンとアムロジピンまたはその塩を含有する安定化された医薬組成物
US9387250B2 (en) 2013-03-15 2016-07-12 Rutgers, The State University Of New Jersey Therapeutic compositions for bone repair

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1241844A (en) 1968-08-23 1971-08-04 Beecham Group Ltd Penicillins
GB1508977A (en) 1974-04-20 1978-04-26 Beecham Group Ltd Beta-lactam antibiotic from streptomyces clavuligerus
US4098897A (en) * 1975-04-14 1978-07-04 Beecham Group Limited Anti bacterial agents
JO984B1 (en) * 1977-10-11 1979-12-01 بيتشام غروب ليمتد A dry pharmaceutical compound with a suitable dosage unit for oral administration
NZ198241A (en) * 1980-09-27 1983-12-16 Beecham Group Ltd Tablet containing amoxycillin and potassium clavulanate
EP0080862B1 (en) * 1981-12-02 1985-09-25 Beecham Group Plc Pharmaceutical formulation comprising beta-lactam antibiotics
GB9408117D0 (en) * 1994-04-23 1994-06-15 Smithkline Beecham Corp Pharmaceutical formulations
AU767177B2 (en) * 1999-04-13 2003-11-06 Beecham Pharmaceuticals (Pte) Limited Novel method of treatment
WO2002030392A2 (en) * 2000-10-12 2002-04-18 Beecham Pharmaceuticals (Pte) Limited Formulation containing amoxicillin

Also Published As

Publication number Publication date
ATE196845T1 (de) 2000-10-15
PT1093813E (pt) 2003-02-28
HK1027024A1 (en) 2001-01-05
EP0758235A1 (en) 1997-02-19
EP1093813A3 (en) 2001-05-30
IL113433A (en) 2003-06-24
JPH09512027A (ja) 1997-12-02
EP1243267A2 (en) 2002-09-25
ES2152485T3 (es) 2001-02-01
OA10377A (en) 2001-11-21
ES2182754T3 (es) 2003-03-16
AP564A (en) 1996-11-21
SK135496A3 (en) 1997-05-07
BG100933A (en) 1997-07-31
BG62842B1 (bg) 2000-09-29
HUT76335A (en) 1997-08-28
EP1093813B1 (en) 2002-10-16
EP0761218B1 (en) 2000-10-11
PT761218E (pt) 2001-03-30
HU9602922D0 (en) 1996-12-30
AP9500733A0 (en) 1995-04-30
ES2180251T3 (es) 2003-02-01
ATE226074T1 (de) 2002-11-15
GR3036844T3 (en) 2002-01-31
EP0978276A3 (en) 2000-04-12
DE69519093D1 (de) 2000-11-16
EP1243267A3 (en) 2002-10-30
HK1009936A1 (en) 1999-06-11
WO1995028927A1 (en) 1995-11-02
AP9600868A0 (en) 1996-10-31
ZA953236B (en) 1995-12-27
FI964249A0 (fi) 1996-10-22
DZ1876A1 (fr) 2002-02-17
DE69528204D1 (de) 2002-10-17
EP0978276B1 (en) 2002-09-11
AT5349U1 (de) 2002-06-25
NO310703B1 (no) 2001-08-20
ES2161288T3 (es) 2001-12-01
CZ294168B6 (cs) 2004-10-13
DE69521799T2 (de) 2002-06-13
DE69528204T2 (de) 2003-08-07
ATE223706T1 (de) 2002-09-15
SA95160343B1 (ar) 2005-05-04
HK1050992A1 (en) 2003-07-18
GB9408117D0 (en) 1994-06-15
IL113433A0 (en) 1995-07-31
DE69521799D1 (de) 2001-08-23
HK1021860A1 (en) 2000-07-07
MA23528A1 (fr) 1995-12-31
NO964488D0 (no) 1996-10-22
BR9507502A (pt) 1997-09-02
CZ11376U1 (cs) 2001-07-12
DK0761218T3 (da) 2000-12-18
EP0761218A1 (en) 1997-03-12
HU228399B1 (en) 2013-03-28
RO116997B1 (ro) 2001-09-28
PT758235E (pt) 2001-10-31
AT5350U1 (de) 2002-06-25
DK0758235T3 (da) 2001-10-29
SK282594B6 (sk) 2002-10-08
CZ309096A3 (en) 1997-04-16
FI964249L (fi) 1996-10-22
RU2152213C1 (ru) 2000-07-10
DE69519093T2 (de) 2001-07-19
GR3035031T3 (en) 2001-03-30
CN1149829A (zh) 1997-05-14
HK1036404A1 (en) 2002-01-04
CN1134258C (zh) 2004-01-14
AU684949B2 (en) 1998-01-08
EP0758235B1 (en) 2001-07-18
NO964488L (no) 1996-12-17
ATE203161T1 (de) 2001-08-15
DK0978276T3 (da) 2003-01-20
MY115351A (en) 2003-05-31
NZ285080A (en) 1998-05-27
SI0758235T1 (en) 2001-10-31
DE29522153U1 (de) 2000-04-06
PT978276E (pt) 2003-01-31
JP3622975B2 (ja) 2005-02-23
PL316966A1 (en) 1997-03-03
DE69528608T2 (de) 2003-06-26
EP0978276A2 (en) 2000-02-09
DE69528608D1 (de) 2002-11-21
CA2188496A1 (en) 1995-11-02
FI964249A7 (fi) 1996-10-22
US6051255A (en) 2000-04-18
EP1093813A2 (en) 2001-04-25
AU2406895A (en) 1995-11-16

Similar Documents

Publication Publication Date Title
DK1093813T3 (da) Fremgangsmåde til at fremstille polymer-overtrukket tablet, der omfatter amoxycillin og clavunalat, belagt med et vandigt polymerfilmovertræk
DE69016433D1 (de) Beschichtungsverfahren und -vorrichtung.
NO894864L (no) Belagt forglasseringsmateriale og fremgangsmaate for belegging av dette.
NO894865L (no) Belagt forglasseringsmateriale og fremgangsmaate for belegging derav.
NL1001008C2 (nl) Bekleed substraat en werkwijze voor de vorming ervan.
EP0618504A3 (en) Method and device for applying a film.
DE69105605D1 (de) Beschichtungsverfahren.
FI944171A7 (fi) Substraattien päällystykseen soveltuvia tahnoja, manetelmä niiden valmistamiseksi sekä niiden käyttö
DE69612216D1 (de) Metallblech mit rostpreventiver organischer beschichtung, verfahren zu dessen herstellung und behandlungsflüssigkeit dafür
FI844660A7 (fi) Kiinteällä muovipäällyksellä varustetut säiliöt, niitä varten tarkoitetut muovipäällykset ja menetelmä päällysten asettamiseksi.
DE69506854D1 (de) Härtbare harzzusammensetzung, beschichtungszusammensetzung, beschichtungsmethode und beschichteter gegenstand
DK0633070T3 (da) Fremgangsmåde til pulvercoating til emner
BR9711032B1 (pt) comprimido de maleato de trimebutina revestido com pelÍcula e processo de preparo do mesmo.
DE69112222D1 (de) Beschichtungsverfahren.
FI940129A7 (fi) Menetelmä ja laite gelatiinipäällystyksen aikaansaamiseksi
FI960560L (fi) Menetelmä filminsiirtopäällystyksessä ja menetelmän toteuttamiseen tarkoitettu laitteisto
FI912692A7 (fi) Paperinpäällystysmenetelmä ja -laite
DE69521465D1 (de) Benzisoselen-azoline und-azine-derivate, verfahren zu deren herstellung und ihre therapeutische verwendung
EE03248B1 (et) Hüdroksüpropüülmetüültselluloosi sisaldava kattega ranitidiinitablett ja nimetatud katte saamise protsess
IT9047538A0 (it) Prodotto rivestito e metodo per rivestirlo.
NO941997D0 (no) Fremgangsmåte for belegging av fröplante og system for fremgangsmåtens utförelse
DE69504488D1 (de) Härtbare harz- und beschichtungs-zusammensetzung, beschichtungsverfahren und beschichteter gegenstand
UA1670S (uk) Прилад для нанесення фарбувальних, клейких, коректувальних та інших рідин
MX9205742A (es) Metodo y aparato para aplicar un revestimiento, auxiliado ultrasonicamente.
FI950338L (fi) Menetelmä pinnoituspaksuuden mittaamiseksi paperia pinnoitettaessa, menettely menetelmän suorittamiseksi, ja laitteiston käyttö